Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Article Type
- Review1
- Clinical Trial1
- Case Reports1
- Clinical Study1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Cancer1
Search Results
Sort by
- Bookedited by Susan M. DeNisco, Anne M. Barker.Summary: "Advanced Practice Nursing: Essential Knowledge for the Profession, Third Edition is a core advanced practice text used in both Master's Level and DNP programs. The Third Edition is a unique compilation of existing chapters from a variety of high-level Jones & Bartlett Learning works creating a comprehensive and well-rounded resource for the advanced practice nursing student. Similar to the previous edition, The Third Edition is framed around the AACN's Master's Essentials as well as the Essentials for Doctoral Education featuring the most up-to-date content on each set of Essentials. Throughout the Third Edition the authors address the rapid changes in the health care environment with a special focus on health care finance, electronic health records, quality and safety as well as emerging roles for the advanced practice nurse. Patient care in the context of the advanced nursing role is also discussed."--Publisher's website.
Contents:
Professional roles for the advanced practice nurse
Healthcare delivery and health policy for advanced practice : core knowledge
Quality, safety, and information systems for advanced practice nurses
Theoretical foundations, research, and evidence-based practice
The role of race, culture, ethics, and advocacy in advanced nursing practice
Leadership and role transition for the advanced practice nurse.Digital Access R2Library 2016Limited to 1 simultaneous user - ArticleWong PP, Yagoda A.Cancer. 1978 Apr;41(4):1256-60.Thirty-nine chemotherapy trials in 16 patients with metastatic hemangiopericytoma treated at MSKCC and 33 trials from the literature are reviewed. Adriamycin, alone or in combination drug regimens, is the most effective agent, producing complete and partial remission in 50% of cases. Other drugs which show some activity include vincristine, cyclophosphamide, actinomycin, methotrexate and DTIC. The available data indicate malignant hemangiopericytoma should be considered chemotherapeutically responsive tumors.